242 related articles for article (PubMed ID: 8761302)
1. Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells.
Lutz W; Stöhr M; Schürmann J; Wenzel A; Löhr A; Schwab M
Oncogene; 1996 Aug; 13(4):803-12. PubMed ID: 8761302
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
[TBL] [Abstract][Full Text] [Related]
3. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
[TBL] [Abstract][Full Text] [Related]
4. Sequences flanking the E-box contribute to cooperative binding by c-Myc/Max heterodimers to adjacent binding sites.
Walhout AJ; van der Vliet PC; Timmers HT
Biochim Biophys Acta; 1998 Apr; 1397(2):189-201. PubMed ID: 9565685
[TBL] [Abstract][Full Text] [Related]
5. Expression of myc-family, myc-interacting, and myc-target genes during preimplantation mouse development.
Domashenko AD; Latham KE; Hatton KS
Mol Reprod Dev; 1997 May; 47(1):57-65. PubMed ID: 9110315
[TBL] [Abstract][Full Text] [Related]
6. Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastoma.
Sasaki H; Sato Y; Kondo S; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
Cancer Lett; 2001 Jul; 168(2):191-5. PubMed ID: 11403924
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Myc targets in c-myc and N-myc induced human tumors.
Ben-Yosef T; Yanuka O; Halle D; Benvenisty N
Oncogene; 1998 Jul; 17(2):165-71. PubMed ID: 9674700
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation by Myc is under negative control by the transcription factor AP-2.
Gaubatz S; Imhof A; Dosch R; Werner O; Mitchell P; Buettner R; Eilers M
EMBO J; 1995 Apr; 14(7):1508-19. PubMed ID: 7729426
[TBL] [Abstract][Full Text] [Related]
9. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.
Tobias KE; Shor J; Kahana C
Oncogene; 1995 Nov; 11(9):1721-7. PubMed ID: 7478599
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
12. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
Packham G; Cleveland JL
Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
[TBL] [Abstract][Full Text] [Related]
13. Cell-cycle progression is not essential for c-Myc to block differentiation.
Ryan KM; Birnie GD
Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
[TBL] [Abstract][Full Text] [Related]
14. Position and orientation independent transactivation by c-Myc.
Packham G; Bello-Fernandez C; Cleveland JL
Cell Mol Biol Res; 1994; 40(7-8):699-706. PubMed ID: 7787888
[TBL] [Abstract][Full Text] [Related]
15. Unsaturated fatty acids bind Myc-Max transcription factor and inhibit Myc-Max-DNA complex formation.
Chung S; Park S; Yang CH
Cancer Lett; 2002 Dec; 188(1-2):153-62. PubMed ID: 12406560
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of c-myc family genes in thymuses from myasthenia gravis patients.
Nagata T; Onodera H; Ohuchi M; Suzuki Y; Tago H; Fujihara K; Ishii N; Sugamura K; Shoji Y; Handa M; Tabayashi K; Itoyama Y
J Neuroimmunol; 2001 Apr; 115(1-2):199-202. PubMed ID: 11282171
[TBL] [Abstract][Full Text] [Related]
17. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
18. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
[TBL] [Abstract][Full Text] [Related]
19. WI-38 cell long-term quiescence model system: a valuable tool to study molecular events that regulate growth.
Soprano KJ
J Cell Biochem; 1994 Apr; 54(4):405-14. PubMed ID: 8014189
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
